Insurer's Class Action Over Trasylol Dismissed
A judge has dismissed a health plan's proposed class action against Bayer Corp. over alleged fraud in the marketing of surgery drug Trasylol, saying the insurer failed to prove that Bayer...To view the full article, register now.
Already a subscriber? Click here to view full article